The working equipment has rolled into the construction site in the Tyumen region, where a new import-substituting production facility, one of the most advanced in the world, is expected to be built within three years.
Vikram Punia, the President of Pharmasyntez Group, announced his strategic plans for the development of division in Tyumen at a working meeting with the Governor Vladimir Yakushev. This includes the establishment of a facility for manufacturing the hormonal products at the existing site. Currently, the monopoly in that area is held by foreign companies.
“There is no such project in Russia. In fact, there is no import substitution in that area,” said the President of Pharmasyntez. “Our project is aimed at strengthening the drug supply security of people in Russia.”
The investments are estimated at 3250 million rubles. Most expenditures will be on purchasing the equipment, design, construction and installation works, as well as on clinical trials and registration of medicinal products.
The project includes the construction of a production building with a surface area of 6000 square meters, establishment of a 350 square meter pilot production shop based on the existing infrastructure of the enterprise, and the construction of an automated warehouse. The production of medicines is scheduled to start in 2020.